BioConvergence LLC Announces Purchase of New CE Instrument

Report 1 Downloads 26 Views
BioConvergence LLC Announces Purchase of New CE Instrument The Product and Analytical Development and Test Laboratory operation at BioConvergence LLC proudly announces it has further enhanced its analytical capability with a recent upgrade to a new Sciex Separations PA800S Plus Pharmaceutical Capillary Electrophoresis (CE) System. CE testing is an important analytical test method in BioConvergence’s laboratory and in any pharmaceutical development program. The CE technique is a valuable tool for the efficient analysis and characterization of complex material samples such as proteins and peptides. CE is especially useful when conducting the following types of activities:    

Stability Studies Purity Studies Potency Assays / Degradation Studies Process and Materials Compatibility Analyses

The new Sciex Separations PA800S Plus Pharmaceutical System unit includes the following features:  

High Resolution Separation Module High Sensitivity Photodiode Array Detector System with Wavelength Range of 190-600 nm Utilizes Beckman Coulter PA800 UV-Vis Sample Storage and Capillary Temperature Control 32 Karat ™ Version 10.1 Windows 7 Operating System and Integrated Data Analysis Capability Solutions for SDS-Mw, cIEF, IgG, Ion Analysis

   

BioConvergence LLC is audited to, and fully compliant with cGMP and ISO requirements as a service provider to the pharmaceutical, animal health and medical device industries. Founded in 2006, the company is a woman-owned business operating in a 70,000 square foot facility in Bloomington, Indiana, within 90 minutes of both FedEx and UPS hubs. The company’s service lines include supply chain operations, drug formulation development, analytical methods development and testing activities, and labeling and kitting operations.



Contact us to discuss requirements: 812.961.1700



Website: www.bioc.us

BioConvergence LLC 4320 West Zenith Drive, Bloomington, IN 47404 BSLO-CE315